We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| K V Pharma CL A | NYSE:KVA | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0 | - |
From Jan 2020 to Jan 2025
Among the companies with shares expected to actively trade in Monday's session are Steel Dynamics Inc. (STLD) and K-V Pharmaceuticals Co. (KVA, KVB)
Steel Dynamics forecast second-quarter earnings below analyst expectations, pointing to a decline in sheet-steel prices. Shares slipped 3.2% to $10.67 after hours.
The Food and Drug Administration said its own analysis of compounded versions of the active ingredient in K-V Pharmaceuticals's premature-birth prevention Makena drug did not identify any major safety problems, but reiterated that approved drugs are generally safer and more effective than compounded products. K-V class A shares surged 16% to $1.22 after hours.
Watchlist:
Drug maker Merck & Co. (MRK) said a U.S. district court ruled against it in a patent-infringement suit involving Apotex Inc.
Health-benefits provider WellPoint Inc. (WLP) said it will pay $90 million to resolve a lawsuit related to its initial public offering and lowered its full-year earnings projections.
-Write to Nathalie Tadena at nathalie.tadena@dowjones.com
1 Year K V Pharma CL A Chart |
1 Month K V Pharma CL A Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
